AIG
IMNM icon

American International Group’s Immunome IMNM Stock Holding History

American International Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,218
Closed -$41 – 3198
2021
Q1 		$41 Buy
1,218
+3
+0.2% +$75 ﹤0.01% 3029
2020
Q4 		$12 Buy
+1,215
New +$14.2K ﹤0.01% 3124

Other funds holding IMNM

AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $244M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

American International Group's IMNM Position: Q2 2021 in Review

American International Group sold out of Immunome (IMNM) in Q2 2021, closing a stake of 1,218 shares — an estimated $41 sold.

American International Group first reported a position in IMNM in Q4 2020 and held it in 2 quarters. The position peaked at $41 in Q1 2021. 29 funds tracked by Wall St. Rank hold IMNM as of Q2 2021.

  • American International Group reported no remaining Immunome position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 1,218 Immunome shares in Q2 2021, an estimated $41.
  • American International Group first reported a position in Immunome in Q4 2020 and held it in 2 quarters.
  • American International Group's Immunome position peaked at $41 in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Immunome as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.